Biologics Engineering - Cell Therapy & Engineering Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

AstraZeneca · 17 hours ago

Biologics Engineering - Cell Therapy & Engineering Intern

positionUS - Gaithersburg - MD
timeInternship
remoteOnsite
seniorityIntern
money$41.50/hr - $48/hr

AstraZeneca is seeking Master's and PhD level students for a 12-week internship role in Biologics Engineering focused on Cell Therapy. The intern will recommend protein targets for CAR-T therapy, generate necessary reagents, run assays, and make recommendations based on data analysis.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & BenefitsbadNo H1Bnote

Responsibilities

Use literature to recommend candidate protein targets to test in CAR-T therapy form
Generate reagents required to make CAR-T therapy including lentivirus and immune cell culture
Run assays culturing their candidate CAR-T therapies with target cells and using flow cytometry to determine therapy efficacy
Make recommendations based on their data on the feasibility of the candidate therapy designs they tested

Qualification

Wet lab skillsFlow cytometryCell cultureData analysisLiterature search

Required

Master's and PhD level students majoring in Biomedical Engineering, Biology, Immunology or a related discipline. Candidates must have an expected graduation date after August 2026
Wet lab skills such as pipetting and aseptic technique for cell culture are required
Ability to report onsite to Gaithersburg, MD 5 days per week; this position may require occasional onsite weekend hours
US Work Authorization is required at time of application
This role will not be providing OPT support

Preferred

Experience with flow cytometry
Literature search and data analysis using Excel and basic stats (e.g. Prism)
Experience with immune cell culture

Company

AstraZeneca

twittertwittertwitter
Glassdoor4.1
company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
dateFounded in 1999
location
Cambridge, Cambridgeshire, GBR
people-size10001+ employees
web-link
https://www.astrazeneca.com

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Executive Director and Chief Executive Officer
leader-logo
Aradhana Sarin
Group CFO and Executive Director
linkedin

Recent News

Pharma Letter
AstraZeneca moves US listing from Nasdaq to NYSE
2026-01-22
Clinical Trials Arena
Genespire to take rare disease gene therapy to clinic in 2026
2026-01-22
Benzinga.com
Big-Pharma Partner Harbour BioMed Boosts Stake In Spruce Biosciences
2026-01-22
Company data provided by crunchbase